Michael Kalos

faculty photo
Adjunct Associate Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
421 Curie Boulevard
552 BRBII/III
Philadelphia, PA 19104
Education:
BS (Biochemistry)
University of Minnesota, 1983.
PhD (Microbiology/Genetics)
University of Minnesota, 1990.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Ascierto Paolo A, Kalos Michael, Schaer David A, Callahan Margaret K, Wolchok Jedd D: Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types. Clinical cancer research : an official journal of the American Association for Cancer Research 19(5): 1009-1020, Mar 2013.

Lacey Simon F, Kalos Michael: Biomarkers in T-cell therapy clinical trials. Cytotherapy Feb 2013.

Tebas Pablo, Stein David, Binder-Scholl Gwendolyn, Mukherjee Rithun, Brady Troy, Rebello Tessio, Humeau Laurent, Kalos Michael, Papasavvas Emmanouil, Montaner Luis J, Schullery Daniel, Shaheen Farida, Brennan Andrea L, Zheng Zhaohui, Cotte Julio, Slepushkin Vladimir, Veloso Elizabeth, Mackley Adonna, Hwang Wei-Ting, Aberra Faten, Zhan Jenny, Boyer Jean, Collman Ronald G, Bushman Frederic D, Levine Bruce L, June Carl H: Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long anti-sense to HIV. Blood Dec 2012.

Gill Saar, Kalos Michael: T cell-based gene therapy of cancer. Translational research : the journal of laboratory and clinical medicine Dec 2012.

McCormack Emmet, Adams Katherine J, Hassan Namir J, Kotian Akhil, Lissin Nikolai M, Sami Malkit, Mujić Maja, Osdal Tereza, Gjertsen Bjørn Tore, Baker Deborah, Powlesland Alex S, Aleksic Milos, Vuidepot Annelise, Morteau Olivier, Sutton Deborah H, June Carl H, Kalos Michael, Ashfield Rebecca, Jakobsen Bent K: Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors. Cancer immunology, immunotherapy : CII Dec 2012.

Kandalaft Lana E, Kalos Michael, Melief Cornelis J M, Speiser Daniel E, Coukos George: Conference scene: Immune signatures in the tumor and beyond. Immunotherapy 4(8): 761-72, Aug 2012.

Liddy Nathaniel, Bossi Giovanna, Adams Katherine J, Lissina Anna, Mahon Tara M, Hassan Namir J, Gavarret Jessie, Bianchi Frayne C, Pumphrey Nicholas J, Ladell Kristin, Gostick Emma, Sewell Andrew K, Lissin Nikolai M, Harwood Naomi E, Molloy Peter E, Li Yi, Cameron Brian J, Sami Malkit, Baston Emma E, Todorov Penio T, Paston Samantha J, Dennis Rebecca E, Harper Jane V, Dunn Steve M, Ashfield Rebecca, Johnson Andy, McGrath Yvonne, Plesa Gabriela, June Carl H, Kalos Michael, Price David A, Vuidepot Annelise, Williams Daniel D, Sutton Deborah H, Jakobsen Bent K: Monoclonal TCR-redirected tumor cell killing. Nature medicine 18(6): 980-7, Jun 2012.

Tchou Julia, Wang Liang-Chuan, Selven Ben, Zhang Hongtao, Conejo-Garcia Jose, Borghaei Hossein, Kalos Michael, Vondeheide Robert H, Albelda Steven M, June Carl H, Zhang Paul J: Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast cancer research and treatment 133(2): 799-804, Jun 2012.

Scholler John, Brady Troy L, Binder-Scholl Gwendolyn, Hwang Wei-Ting, Plesa Gabriela, Hege Kristen M, Vogel Ashley N, Kalos Michael, Riley James L, Deeks Steven G, Mitsuyasu Ronald T, Bernstein Wendy B, Aronson Naomi E, Levine Bruce L, Bushman Frederic D, June Carl H: Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Science translational medicine 4(132): 132ra53, May 2012.

Kalos Michael: Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses. Cancer immunology, immunotherapy : CII 61(1): 127-35, Jan 2012.

back to top
Last updated: 03/29/2013
The Trustees of the University of Pennsylvania